Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI...
Brain
Epilepsy Foundation Awards $200,000 at 12th Annual Shark Tank Competition
BOWIE, Md., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Epilepsy Foundation announced today it has awarded $200,000 in funding for two...
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade glioma CLD-101 is Calidi’s novel allogeneic...
Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra
MALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),...
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer’s Disease
Boca Raton, Florida, Sept. 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company...
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE / September 27,...
Nexstim Receives Order for NBS System 5 in Finland
Press release, Helsinki, 27 September 2024 at 10 AM (EEST) Nexstim Receives Order for NBS System 5 in Finland Nexstim...
AIRAmed and Memory Treatment Centers (Bonita Springs and Jacksonville, Florida) have launched a research partnership aimed at studying Alzheimer’s disease in cognitively impaired individuals undergoing anti-amyloid therapy
As the global Alzheimer's community enters a new era of drug treatments, we at MTC are excited to announce our...
Brain Cancer Support and Solutions Alliance Launches Dedicated Nurse Navigator for Comprehensive Patient and Caregiver Assistance
KANSAS CITY, Mo. and HEWLETT, N.Y. and PALO ALTO, Calif., Sept. 26, 2024 /PRNewswire/ -- The Brain Cancer Support and Solutions...
ISS National Lab Sponsoring Botanical, Cardiac, and Genetic Research During Five-Month Science Mission to Orbiting Outpost
During NASA's SpaceX Crew-9 mission to the space station, the crew will support dozens of projects sponsored by the ISS...
2024 Collegiate Inventors Competition Finalists Showcase the Future of American Innovation
NORTH CANTON, Ohio, Sept. 26, 2024 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries...
Datasea Announces Fiscal Year 2024 Financial Results with Revenue 6.6x that of 2023 Primarily due to Growth of its 5G AI Business
The Total Value of 5G-AI Contracts Currently in Process Exceeds $100 MM BEIJING, Sept. 26, 2024 /PRNewswire/ -- Datasea Inc....
Groundbreaking Study Explores the Science Behind Precognition and Intuition
PUERTO DE SANTA MARIA, Spain, Sept. 26, 2024 /PRNewswire/ -- In his book, Contact with the Future: The Astonishing Power of...
New England’s Life Sciences, Medical, and Health Tech Pros: ‘Mission-Driven High Performers’
Brodeur Partners Launches New Relevance Research at Inaugural TEDxNewEngland Conference Showcasing Insights into New England's Workforce in Science-Based Industries BOSTON,...
Interim results for the six months ended June 30, 2024
September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024...
The Ultrasound Event 2025: Pioneering the Future of Medical Ultrasound
ORLANDO, Fla., Sept. 25, 2024 /PRNewswire/ -- The American Institute of Ultrasound in Medicine (AIUM) is excited to announce the...
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Invests More Than $7 Million in C2N Diagnostics’ Blood Tests
New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics.Blood tests will be key to...
Linus Health to Unveil New Tools for Earlier Dementia Detection at AAFP’s FMX ’24
Chief Strategy Officer Dr. John Showalter will also explain during FMX Med Talk why early detection of cognitive impairment by...